Steven Cohen (Point72) exit BioMarin Pharmaceutical Inc.
Steven Cohen (Point72) exit $-117.5M of disclosed value in BioMarin Pharmaceutical Inc..
Signal
Investor Move
Action
Exit
Capital
$-117.5M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.